Osaic Holdings’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2K Buy
120,204
+118,860
+8,844% +$33.2K ﹤0.01% 6205
2026
Q1
$441 Sell
1,344
-1,131
-46% -$1.78K ﹤0.01% 7459
2025
Q4
$7.67K Sell
2,475
-25,800
-91% -$73.6K ﹤0.01% 6484
2025
Q3
$70.1K Buy
28,275
+126
+0.4% +$278 ﹤0.01% 5078
2025
Q2
$34.6K Buy
28,149
+654
+2% +$713 ﹤0.01% 5307
2025
Q1
$30.2K Buy
27,495
+51
+0.2% +$59 ﹤0.01% 5075
2024
Q4
$24.7K Buy
27,444
+26,095
+1,934% +$22.4K ﹤0.01% 5194
2024
Q3
$1.33K Hold
1,349
﹤0.01% 6749
2024
Q2
$1.22K Buy
1,349
+900
+200% +$673 ﹤0.01% 6758
2024
Q1
$529 Buy
449
+54
+14% +$59 ﹤0.01% 6803
2023
Q4
$359 Sell
395
-205
-34% -$151 ﹤0.01% 6941
2023
Q3
$499 Buy
600
+300
+100% +$346 ﹤0.01% 6988
2023
Q2
$360 Sell
300
-555
-65% -$691 ﹤0.01% 7114
2023
Q1
$1.08K Buy
855
+189
+28% +$362 ﹤0.01% 6929
2022
Q4
$2K Buy
666
+322
+94% +$2.65K ﹤0.01% 6652
2022
Q3
$5K Hold
344
﹤0.01% 6357
2022
Q2
$3K Sell
344
-2,650
-89% -$20.5K ﹤0.01% 6721
2022
Q1
$26K Sell
2,994
-978
-25% -$9.43K ﹤0.01% 5521
2021
Q4
$45K Sell
3,972
-195
-5% -$2.32K ﹤0.01% 5229
2021
Q3
$52K Buy
4,167
+600
+17% +$5.52K ﹤0.01% 5064
2021
Q2
$29K Buy
3,567
+2,350
+193% +$20.4K ﹤0.01% 5419
2021
Q1
$11K Sell
1,217
-16
-1% -$161 ﹤0.01% 5820
2020
Q4
$12K Sell
1,233
-200
-14% -$1.97K ﹤0.01% 5431
2020
Q3
$17K Buy
1,433
+500
+54% +$6.63K ﹤0.01% 4998
2020
Q2
$12K Buy
933
+15
+2% +$189 ﹤0.01% 5088
2020
Q1
$9K Buy
+918
New +$12K ﹤0.01% 5061

Other funds holding GOSS

Osaic Holdings's GOSS Position: Q2 2026 in Review

Osaic Holdings increased its Gossamer Bio (GOSS) stake by 8,844% in Q2 2026, buying an estimated $33.2K and bringing the position to 120,204 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6205.

Osaic Holdings first reported a position in GOSS in Q1 2020 and has held it in 26 quarters since. The position peaked at $70.1K in Q3 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Osaic Holdings held 120,204 shares of Gossamer Bio worth $19.2K as of Q2 2026.
  • Osaic Holdings bought 118,860 Gossamer Bio shares in Q2 2026, an estimated $33.2K.
  • Gossamer Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6205 holding.
  • Osaic Holdings first reported a position in Gossamer Bio in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Gossamer Bio position peaked at $70.1K in Q3 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.